If you made any changes in Pure these will be visible here soon.

Personal profile


Dr Sudha Rao obtained her BSC (Hons.) degree at Keele University, UK. She subsequently joined Aventis and as a Senior Scientist was involved in developing therapeutics strategies in the arena of asthma & COPD.

Sudha received a prestigious Aventis Fellowship and obtained her PhD from the University of London, Kings College in 2000. During this period, she joined a team of scientists at Aventis Pharma to establish the first therapeutic microarray screening platform in the UK in collaboration with Affymetrix, USA.

Sudha was recruited by Professor Shannon (Gene Expression and Epigenomics Group) as a postdoctoral fellow to JCSMR, ANU in 2000. In 2003 she was appointed as a research fellow (Level B) and in 2009, Sudha was appointed Team Leader of the Immune Regulation & Nuclear Dynamics Group at JCSMR, ANU.

Sudha moved to the University of Canberra in 2010 as an Associate Professor in Molecular & Cellular Biology and is also on the staff of the Centre for Research in Therapeutic Solutions (CResTS).

Sudha has extensive experience in transcriptional biology and genomic technologies that spans both pharmaceutical and academic settings. The primary focus of Sudha's research group has been to unravel complex epigenetic-signatures in transcription programs in the context of the immune system, as well as to understand the deregulatory mechanisms operating in cancer settings.

Research interests

  • Epigenetic regulation
  • Breast cancer and cancer stem cells
  • Memory T cells


Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 3 Similar Profiles
T-Lymphocytes Medicine & Life Sciences
Chromatin Medicine & Life Sciences
Epigenomics Medicine & Life Sciences
Genes Medicine & Life Sciences
Protein Kinase C Medicine & Life Sciences
Neoplastic Stem Cells Medicine & Life Sciences
Epithelial-Mesenchymal Transition Medicine & Life Sciences
T-cells Chemical Compounds

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2011 2020

Research Output 2005 2017

15 Citations

Epigenetics and immunotherapy: The current state of play

Dunn, J. & Rao, S. 1 Jul 2017 In : Molecular Immunology. 87, p. 227-239 13 p.

Research output: Contribution to journalArticle

Tumor Microenvironment
Tumor Escape
1 Citations

Priming of transcriptional memory responses via the chromatin accessibility landscape in T cells

HARDY, K., Li, J., DUNN, J., Brezar, V., Morris, M., Denyer, G., Lee, S., Turner, S. J., seddiki, N., Smith, C., Khanna, R. & RAO, S. 2017 In : Scientific Reports. 7, p. 1-20 20 p.

Research output: Contribution to journalArticle

Nucleic Acid Regulatory Sequences
6 Citations

The biological and clinical significance of stromal-epithelial interactions in breast cancer

Wu, F., DUNN, J., RAO, S. & Dahlstrom, J. 2017 In : Pathology. 49, 2, p. 133-140 8 p.

Research output: Contribution to journalArticle

Tumor Microenvironment
Breast Neoplasms
Cellular Microenvironment
15 Citations

Differential roles for DUSP family members in epithelial-to-mesenchymal transition and cancer stem cell regulation in breast cancer

BOULDING, T. R., Wu, F., MCCUAIG, R., DUNN, J., SUTTON, C., HARDY, K., Tu, W., Bullman, A., Yip, D., Dahlstrom, J. & RAO, S. 2016 In : PLoS ONE. 11, 2, p. 1-23 23 p.

Research output: Contribution to journalArticle

Dual-Specificity Phosphatases
Epithelial-Mesenchymal Transition
Neoplastic Stem Cells
Stem cells
Mesenchymal Stromal Cells
4 Citations

Identification of chromatin accessibility domains in human breast cancer stem cells

HARDY, K., Wu, F., ZAFAR, A., Theodoratos, A. & RAO, S. 2016 In : Nucleus. 7, 1, p. 50-67 18 p.

Research output: Contribution to journalArticle

Neoplastic Stem Cells
Epithelial-Mesenchymal Transition
Breast Neoplasms
Transcription Factor AP-1